Records containing: Polypoidal Choroidal Vasculopathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-06-17ClinicalTrials.gov study NCT02597855
-
CLINICAL_TRIALS study record update · 2016-04-29An Single Arm, Single Dose Study to Evaluate the Effect of Intravitreal Injection of VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2014-11-05Phase I Study of Ranibizumab Injection for Polypoidal Choroidal Vasculopathy (PEARL)
-
CLINICAL_TRIALS study record update · 2014-06-23Treatment of Polypoidal Choroidal Vasculopathy With Ranibizumab(Lucentis): A Phase I/II Safety Study.
-
CLINICAL_TRIALS study record update · 2012-10-25Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy With Intravitreal Injection of Lucentis (Ranibizumab Injection)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-11-01OXiGENE OXC402-201: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Biological Effects of Intravenous Fosbretabulin in Asian Subjects With Polypoidal Choroidal Vasculopathy (PCV)
-
CLINICAL_TRIALS study record update · 2011-05-30ClinicalTrials.gov study NCT01360151
-
CLINICAL_TRIALS study record update · 2011-01-25A Multicentre, Randomized, Double Masked, Exploratory, Indocyanine Green Angiography (ICGA) Guided Study of 6 Months Duration to Compare the Safety and Effect on Polyp Regression of Verteporfin Photodynamic Therapy (PDT) Alone or Added to Ranibizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy
-
CLINICAL_TRIALS study record update · 2011-01-06Association of Complement Factor H and ARMS2 Genotypes With Response of Polypoidal Choroidal Vasculopathy to Intravitreal Ranibizumab
-
CLINICAL_TRIALS study record update · 2010-11-25Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively
-
CLINICAL_TRIALS study record update · 2007-09-26Off-Label Use of AVASTIN (BEVACIZUMAB)Intravitreal Injection For the Treatment of Serosanguinous Maculopathy
-
CLINICAL_TRIALS study record update · 2006-10-04Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy